Melrilimab

未知生产厂商

Melrilimab is under investigation in clinical trial NCT03207243 (Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Melrilimab is under investigation in clinical trial NCT03207243 (Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

未检索到以该名称命名的专利

专利文献通常使用化学名或研发代号指代药物，而非通用名；且专利申请在提交约 18 个月后才公开，较新的药物可能尚未出现在这里。